Outlook Therapeutics Inc - Advancing Toward Commercial Launch of Lytenava™ (Bevacizumab Gamma) in EU Expected in Calendar Q1 2025
Outlook Therapeutics Inc——預計將於2025年第一季度在歐盟商業推出Lytenava™(Bevacizumab Gamma)
Outlook Therapeutics Inc - Advancing Toward Commercial Launch of Lytenava™ (Bevacizumab Gamma) in EU Expected in Calendar Q1 2025
Outlook Therapeutics Inc——預計將於2025年第一季度在歐盟商業推出Lytenava™(Bevacizumab Gamma)
譯文內容由第三人軟體翻譯。